Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
VisionWave Holdings Closes and Funds $20 Million Senior Financing
-
UroGen Announces ZUSDURI™ Launch is On-Track and Reports Fourth Quarter and Full Year 2025 Financial Results
-
Levanta Unifies Creator and Affiliate Programs Across Shopify, Amazon, and Walmart
-
newcleo subsidiary S.R.S. awarded USD 42 million contracts with Romania’s RATEN to build lead-cooled nuclear reactor research facilities
-
Tectonic Therapeutic to Participate in March Investor Conferences
-
Meltwater’s Doug Balut Named to CRN 2026 Channel Chiefs List as Partner Program Scales Globally
-
SSC Space Deploys Kratos’ OpenSpace® Platform in its New Service for LEO Missions: SSC Space Go
-
Roper Technologies to present at Morgan Stanley technology conference
-
StepStone Real Estate Awarded Global Indirect Firm of the Year and European Deal of the Year in PERE 2025 Awards
-
Deep Isolation Appoints Nuclear Operations Leader Matthew Sunseri to Advisory Board to Strengthen Safety and Regulatory Expertise
-
Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference
-
UK Manufacturer Basic Prints Commits to Digital-First Production Model with Dual Investment in Kornit Digital’s Apollo
-
Collegium to Participate in Upcoming Investor Conferences
-
Ardena Appoints Paul Edwards as Chief People Officer
-
GetYourGuide Appoints Rob Rekrutiak as Chief Product Officer
-
Evaxion to announce business update and full year 2025 financial results on March 5, 2026
-
ASML reports transactions under its current share buyback program
-
Artios Reports Randomized Phase 2a Study of Low Dose Alnodesertib Plus Gemcitabine Achieves Primary Endpoint in Platinum-Resistant Ovarian Cancer
-
Yukon Metals Appoints Jim Coates as Permanent Full-Time CEO
-
UroGen Announces Refinanced Term Loan Agreement with Pharmakon Advisors
-
SL Green Promotes Harrison Sitomer to President and Chief Investment Officer
-
Dan Herbatschek of Ramsey Theory Group Warns Most Enterprises Cannot Quantify AI Risk and Launches Structured AI Risk Quantification Framework
-
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.085 per Share for March 2026
-
Open Cosmos Announces ConnectedCosmos: A European Alternative for Secure Space-Based Connectivity & Operational Resilience
-
Election of employee representatives to the Board of Directors of Danske Bank A/S
-
SL Green Signs Office Leases Totaling 490,000 Square Feet During the First Two Months of 2026
-
VirPoint Unveils Hybrid AI Division: Fusing Machine Precision with Elite Human Financial Expertise
-
Nykredit Realkredit A/S to redeem Subordinated Notes - Nykredit Realkredit A/S
-
Wrap and WOFT Establish Drone Test & Non-Lethal Response Training Site in Florida
-
Altimmune to Participate in Upcoming Investor Conferences
-
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM
-
Highland Copper Closes Sale of 34% Interest in White Pine for US$30 Million
-
SL Green and Jeff Sutton Sell 690 Madison Avenue
-
BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets
-
Palvella Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
Trevi Therapeutics to Participate in Upcoming March Conferences
-
One Bullion Announces Share Consolidation
-
Cognition Therapeutics Advancing Zervimesine (CT1812) for Dementia with Lewy Bodies (DLB) Psychosis
-
Winshear Gold Closes Private Placement
-
TEGNA Inc. Reports Fourth Quarter and Full-Year 2025 Results
-
Telkomsel Expands Capsyl Cloud Deployment with Synchronoss
-
Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
-
Zevra Therapeutics Announces Details for Q4 and Full Year 2025 Financial Results Call
-
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Nexxen Announces February 2026 Share Repurchase Program Summary
-
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution
-
Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the Urgent Need for Disease-Modifying Treatments
-
Djezzy and Qvantel Extend Partnership to Accelerate Digital Services Growth
-
Statkraft AS: Release of fourth quarter results 2025 and annual report for 2025
-
Zoomex: On Traditional Gold Market Closure, On-Chain Gold Surges Amid Black Swan Events — XAUT-USDT Becomes a Focus for Risk Hedging
